Solution & Team Overview

Solution name:

DrugStoc

Add a comment

Read comments
No comments to show.

Short solution summary:

Data-driven, transparent and end-to-end supply chain for essential medicines in emerging Economies

Add a comment

Read comments
No comments to show.

In what city, town, or region is your solution team based?

Lagos, Nigeria
Add a comment

Read comments
No comments to show.

Who is the Team Lead for your solution?

Chibuzo Opara

Add a comment

Read comments
No comments to show.

Which Challenge Area does your solution most closely address?

Respond (Decrease transmission & spread), such as: Optimal preventive interventions & uptake maximization, Cutting through “infodemic” & enabling better response, Data-driven learnings for increased efficacy of interventions
Add a comment

Read comments
No comments to show.

What specific problem are you solving?

In 2016, I lost my Dad who was a professor of Surgery to poor access to his essential medicines. This is not an isolated case, today, less than 10% of 100,000+ health care providers in Nigeria have access to transparent, free flow, and visibility of essential medicines and genuine medical products when they need it the most. According to WHO, this is one of the biggest challenges in the pharmaceutical supply chain in emerging economies. 

In Africa for instance, an inefficient and bureaucratic supply system is often plagued by poor procurement practices that make drugs very costly or unavailable to the patients that need them the most.

Likewise, healthcare providers like pharmacies, Patent and Proprietary Medicine Vendors (PPMVs), doctors, maternity and nursing homes struggle with procuring or accessing real-time, transparent and counterfeit-proof medical products.

Added to these are the poor transportation system, a lack of storage facilities for pharmaceutical products and insufficiently regulated leading to a massive influx of fake and substandard medicines to the supply chain, making it difficult for the hard reach, voiceless poor to access quality safe medications.

Add a comment

Read comments
No comments to show.

Who does your solution serve, and what needs of theirs does it address?

Our target audience is Licensed community pharmacies, chain pharmacies, hospitals, clinics, patent and proprietary medicine vendors (PPMVs), Maternity and nursing homes. Through our partners we seek to transform the lives of the lower socio-economic groups across 16 cities and 90 million people in the next 2 years. 

Add a comment

Read comments
No comments to show.

What is your solution’s stage of development?

Growth: An initiative, venture, or organisation with an established product, service, or business/policy model rolled out in one or, ideally, several contexts or communities, which is poised for further growth
Add a comment

Read comments
No comments to show.
More About Your Solution

Please select all the technologies currently used in your solution:

  • Big Data
  • GIS and Geospatial Technology
  • Software and Mobile Applications
Add a comment

Read comments
No comments to show.

What “public good” does your solution provide?

DrugStoc social impact revolves around;

  • Expanding access to cost-effective, transparent, quality and genuine essential medicines for low socio-economic groups of patients and individuals in Sub-Saharan Africa

  • Empowering the healthcare providers with the improved financial wellbeing from doing business with DrugStoc leading to a positive ripple effect on the surrounding community’s healthcare and prosperity

  • Data transparency in the Pharma industry

Add a comment

Read comments
No comments to show.

How will your solution create tangible impact, and for whom?

Community Pharmacies (CP) - Every product CP’s are buying from DrugStoc reduces the chances of them buying counterfeit or substandard versions of the same product.

Private Practice - Offer unhindered access to doctors, Traditional Birth Attendants, and Nurse-led organisations. Reduces cost to patient significantly by ensuring all medications are accessible to them at wholesale prices (No Minimum order quantity)

Small-mid sized hospitals - Access to quality generics. Enhance quality and cost of healthcare for insurance companies.

Unregulated Medicine vendors - Access to OTC medication and trade alternatives at prices inaccessible to them that in turn reduce their need to sell antibiotics or other controlled medication.

Industry-wide impact - A true alternative to Open Drug Market for health providers and data transparency


Add a comment

Read comments
No comments to show.

How will you scale your impact over the next one year and the next three years?

Post-Series A which we just completed, Our timeline for the next 3 years include

BY END OF YEAR 1 - Onsite presence in 3 cities, delivering 15 million prescriptions (through our end to end tech-enabled supply chain ) to 7,000 health care providers annually

BY END OF YEAR 2 - Onsite presence in 7 cities delivering 30 million prescriptions (through our end to end tech-enabled supply chain ) to 10,000 health care providers annually

BY END OF YEAR 3-  Onsite presence in 15 cities delivering 90  million prescriptions to 16000 health care providers annually

Add a comment

Read comments
No comments to show.

How are you measuring success against your impact goals?

15% in data visibility and transparency in the medical products supply chain industry in sub-Saharan Africa by year 3.

Add a comment

Read comments
No comments to show.

In which countries do you currently operate?

  • Nigeria
Add a comment

Read comments
No comments to show.

In which countries do you plan to deploy your solution within the next 3 years?

  • Ghana
  • Kenya
  • Tanzania
Add a comment

Read comments
No comments to show.

What barriers currently exist for you to accomplish your goals in the next year and the next 3 years? How do you plan to overcome these barriers?

Even though we are united by food, languages, culture and common social issues in sub-Saharan Africa, Every country has varying Pharma policy and regulatory frameworks.

Like we've demonstrated in Nigeria by obtaining a license from the Pharmacists Council of Nigeria(PCN), our plans will be to work and obtain a license with regulatory bodies in every country we expand to.  We expect varying levels of barriers as regards policy and political stability in every city we expand to in sub-Saharan Africa.


Add a comment

Read comments
No comments to show.

If you have additional video content that explains your solution, provide a YouTube or Vimeo link or upload a video here.

Add a comment

Read comments
No comments to show.
More About Your Team

What type of organisation is your solution team?

For-profit, including B-Corp or similar models
Add a comment

Read comments
No comments to show.

List any organisations that you are formally affiliated with or working for

- Pharmacists Council of Nigeria

- Bill & Melinda gate foundation

- Association of general and private medical practitioners of Nigeria

-International Organization for Standardization

- Jack Ma Foundation

- Ministry of Health 

- Rippleworks Foundation

- Stanford Institute for Innovation in Developing Economies

- Chain Pharmacies, Community Pharmacies, HMOs, Hospitals, Clinics, Public hospitals, Maternity and Nursing Clinics


Add a comment

Read comments
No comments to show.
Partnership & Growth Opportunities

Why are you applying to The Trinity Challenge?

Mentorship


Add a comment

Read comments
No comments to show.

What organisations would you like to partner with, why, and how would you like to partner with them?

Amazon -Tech Advisory

CVS - Advisory

MIT LAB - Research, Technology

Mckesson - Expertise, mentorship and Advisory

UnitedHealthcare - Expertise, mentorship and Advisory

Add a comment

Read comments
No comments to show.

Solution Team

 
    Back
to Top